Surfactant-driven quorum sensing of Pseudomonas aeruginosa in cystic fibrosis Authors: Prathibha Selvamani, James John, Janaki Devi Kumar, Sangeetha Gopalakrishnan, Jagadish Chandra Kumar Mangu, Priyatharshini Thangaraj, Krupakar parthasarathy Published: 2026 ABSTRACT Cystic fibrosis (CF) is a genetic lung disease in which thick mucus builds up in the airways, making patients highly vulnerable to chronic bacterial infections. One of the most problematic bacteria in these infections is Pseudomonas aeruginosa, an adaptable microbe that can survive antibiotics and persist in the lungs for many years. This bacterium uses a communication system called “quorum sensing (QS)” to coordinate group behaviors. Through this system, bacterial cells sense their population density and collectively switch on genes that control toxin production, biofilm formation, and resistance to treatment. In cystic fibrosis lungs, the protective lung surfactant layer, especially a major lipid component called dipalmitoylphosphatidylcholine (DPPC), becomes altered due to chronic inflammation. Emerging evidence suggests that altered surfactant lipids may influence bacterial behavior in addition to reflecting lung damage. Instead, they may actively signal to P. aeruginosa, triggering its QS system earlier than expected. This early activation promotes virulence, biofilm persistence, and long-term infection. This review highlights how host lung lipids interact with bacterial communication networks and discuss how targeting QS using surfactant-inspired molecules may offer new therapeutic strategies. Understanding this host–pathogen interaction could lead to innovative anti virulence treatments that weaken the bacteria without directly killing them, potentially reducing antibiotic resistance. Introduction Pseudomonas aeruginosa is a common opportunistic pathogen and highly versatile Gram-negative bacteria encountered in both environmental and clinical settings (Wood et al. 2023). Pseudomonas aeruginosa is a frequent cause of acute and chronic infections, mainly in immunocompromised patients with burns, ventilator-associated pneumonia, cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), and severe viral infections such as COVID-19 (Qin et al. 2022). Pseudomonas aeruginosa pathogenicity is attributed to a diverse array of virulence factors, including secreted toxins, proteases, and redox-active secondary metabolites such as pyocyanin, which contribute to host tissue damage and immune suppression (Metwaly et al. 2024). Pseudomonas aeruginosa pathogenicity is further enhanced by its ability to form biofilms, which protect bacteria from host defenses and increase antibiotic resistance, thereby promoting chronic infection and treatment failure (Moradali et al. 2017; Jurado-Martín et al. 2021). In addition, P. aeruginosa can acquire resistance to multiple antimicrobial classes, facilitated by efflux pumps, low membrane permeability, and rapid genetic and phenotypic adaptation (Wang et al. 2025). These traits are coordinated by several regulatory networks, among which quorum sensing (QS) is one of the most extensively studied for its ability to coordinated virulence expression, biofilm formation, and metabolic diversity in response to environmental factors encountered during infection (Lakshmana et al. 2013; Schuster and Greenberg 2006; Rutherford and Bassler 2012; Moradali et al. 2017; Jurado-Martín et al. 2021). The QS network of P. aeruginosa comprises the Las, Rhl, and Pseudomonas quinolone signal (PQS) systems, which function as a complex and highly structured regulatory network controlling the expression of hundreds of genes associated with virulence, metabolic adaptation, and biofilm formation (Schuster and Greenberg 2006). Other than regulating pathogenicity, P. aeruginosa QS dynamically responds to host-derived environmental signal during infection, thereby modulating virulence expression to promote long-term persistence (Jurado-Martín et al. 2021; Rutherford and Bassler 2012). Persistence strategies of P. aeruginosa in the cystic fibrosis (CF) lung environment Pseudomonas aeruginosa is frequently isolated from the CF patients and causes disease progression during its colonization. Pseudomonas aeruginosa is strongly associated with increased frequency of pulmonary exacerbations, and plays a major role in elevated morbidity and mortality (Sousa and Pereira 2014; Jurado-Martín et al. 2021). Pseudomonas aeruginosa persists in the CF lung against the intense neutrophilic inflammation and prolonged the antibiotic therapy, underscoring its ability to adapt to a changing environment. The CF airway presents a heterogeneous environment characterized by thick dehydrated mucus, oxidative stress, altered nutrient availability, and reduced antimicrobial pressure. In CF, P. aeruginosa undergoes extensive adaptation changes which facilitates long-term persistence after infection has been established (Sousa and Pereira 2014; Rau et al. 2010). Studies reveal the accumulation of mutations affecting QS regulators in CF isolates is often accompanied by a shift toward a mucoid, biofilm-dominated lifestyle that enhances resistance to antibiotics and host defenses (Bragonzi et al. 2009; Moradali et al. 2017). During chronic CF, isolates tend to lose or attenuate the expression of various virulence determinants, though it does not show a loss of pathogenic potential. Instead, P. aeruginosa exhibits a functional gain of virulence, promoting persistence, immune modulation, and biofilm resilience protecting it from host immunity (Rau et al. 2010; Faure et al. 2018). Such adaptation gives rise to genetically and phenotypically diverse subpopulations within the CF lung, contributing to intra-patient heterogeneity and complicating therapeutic eradication (Bragonzi et al. 2009; Jurado-Martín et al. 2021). QS systems in P. aeruginosa: Las, Rhl, and Pqs systems-regulators and hierarchical interactions QS is a cell density based regulatory mechanism that uses signaling molecules that accumulate with bacterial density increases and activate transcriptional regulators, leading to the coordinated expression of genes involved in virulence, metabolism, and biofilm development (Lee and Zhang 2015a; Rutherford and Bassler 2012). Pseudomonas aeruginosa has a well-developed QS network made up of three connected signaling systems. The Las and Rhl systems, two classic LuxI/LuxR-type circuits, and a third non-LuxI/LuxR pathway regulated by the PQS are examples of the interconnected QS systems found in P. aeruginosa. These three systems are integrated and arranged in an orderly fashion, with the Las system holding the top spot in strain PAO1 under laboratory conditions (Schuster and Greenberg 2006; Lee and Zhang 2015a). Under standard laboratory conditions, these systems work in a hierarchical order, with the Las system at the top and providing positive regulatory control over both the Rhl and Pqs systems (Venturi 2006; Schuster and Greenberg 2006). The Las system includes the autoinducer synthase LasI and the transcriptional regulator LasR. LasI produces the diffusible signal molecule N-(3-oxo-dodecanoyl)-L-homoserine lactone (3-oxo-C12-HSL), which builds up at high cell density and binds to LasR to turn on the transcription of many virulence-related genes, including lasB (elastase) and toxA (exotoxin A), as well as downstream QS regulators (rhlR, rhlI, and pqsR) (Jimenez et al. 2012). Activation of LasR starts the Rhl system, which is made up of RhlI and RhlR and uses N-butyryl-L-homoserine lactone (C4-HSL) as its signaling molecule. At the same time, LasR positively controls the PQS system by activating pqsR (also called mvfR) and genes involved in alkyl-quinolone production (pqsABCDE and pqsH), leading to the formation of PQS and its precursor HHQ (McKnight et al. 2000; Lin et al. 2018). Importantly, the Rhl system negatively controls PQS production, creating a regulatory feedback loop that helps adjust QS activity (Wilder et al. 2011). This hierarchical organization is highly flexible and depends on the conditions. Under environmental stresses related to the CF lung, such as phosphate limitation, QS-regulated gene expression can become mostly independent of LasR, with RhlR taking the main role in virulence regulation (Soto-Aceves et al. 2021). This flexibility allows P. aeruginosa to maintain coordinated group behavior even when the usual QS regulators are disrupted. AmbBCDE and other downstream QS modulators The ambBCDE locus, first associated with the production of the integrated quorum-sensing signal (IQS), encodes a non-ribosomal peptide synthetase (NRPS) biosynthetic cluster that has a wide regulatory effect on QS outputs (Lee and Zhang 2015b). Later biochemical studies showed that the AmbBCDE enzymes produce the antimetabolite L-2-amino-4-methoxy-trans-3-butenoic acid (AMB), which indirectly influences QS signaling pathways (Gulick 2017). Genetic disruption of ambB, ambC, ambD, or ambE results in changed production of PQS, C4-HSL, and downstream QS-regulated virulence factors, including pyocyanin, elastase, and rhamnolipids (Tuon et al. 2022). Functional studies of amb mutants show clear changes in QS hierarchy, virulence expression, and disease-causing ability across multiple infection models, indicating that AmbBCDE functions as a supporting regulatory node within the QS network. In addition to standard QS regulation, amb expression has been linked to host-relevant adaptations seen during chronic CF infection, including iron-uptake pathways such as pyochelin biosynthesis and metabolic adjustment under nutrient-limited conditions (Rojas Murcia et al. 2015; Tuon et al. 2022). Quorum sensing-mediated virulence, adaptation, and social dynamics in P. aeruginosa QS functions as a regulatory mechanism that integrates environmental and host-derived signals to regulate pathogenic behavior during infection. The QS network of P. aeruginosa functions as a global regulatory system that controls the expression of more than 200 genes involved in virulence, metabolism, and biofilm development (John et al. 2016; Schuster et al. 2003; Asfahl et al. 2022) (Table 1)). Through the coordinated activation of the Las, Rhl, and PQS systems, QS synchronizes population-wide behaviors in response to increasing cell density and environmental signals (Lin et al. 2018). The Las system mainly controls the expression of acute virulence factors, including elastases (lasA, lasB), exotoxin A (toxA), and alkaline protease, which contribute to host tissue damage and help the bacteria escape immune defenses (Schuster and Greenberg 2006). Further downstream, the PQS system increases the production of redox-active secondary metabolites such as pyocyanin, which causes oxidative stress, damages epithelial barriers, and alters host immune responses (McKnight et al. 2000; Lee and Zhang 2015b). The Rhl system regulates the production of rhamnolipids, hydrogen cyanide, and other factors that are important for biofilm structure, surface movement, and spread of infection (Moradali et al. 2017). In addition to toxin production, QS is essential for biofilm growth, extracellular matrix formation, and antibiotic tolerance—key features of chronic P. aeruginosa infections in CF lungs (Lee and Zhang 2015b; Jurado-Martín et al. 2021). Importantly, clinical CF isolates often contain lasR mutations while still maintaining strong Rhl- and PQS-dependent virulence, indicating that QS regulatory networks remain active but undergo functional reorganization to support long-term persistence rather than acute cell damage (Feltner et al. 2016; Asfahl et al. 2022) (Table 2). Table 1QS mediated virulence, adaptation, and social dynamics in P. aeruginosaQS systemKey componentsSignal molecule(s)Major regulated functionsSpecific functionReferencesLasLasI (synthase), LasR (regulator)3-oxo-C12-HSLElastase, exotoxin A, proteases, initiation of QS cascadeTop of hierarchy in PAO1; often mutated in CF isolatesSchuster and Greenberg (2006), Jimenez et al. (2012)RhlRhlI, RhlRC4-HSLRhamnolipids, hydrogen cyanide, biofilm maturationCan function independently of Las under CF-like conditionsSoto-Aceves et al. (2021), Asfahl et al. (2022PQSPqsABCDE, PqsH, PqsR (MvfR)PQS, HHQPyocyanin, iron chelation, biofilm structureNegatively regulated by Rhl; interacts with iron metabolismLin et al. (2018), Wilder et al. (2011)IQS/AmbAmbBCDE (NRPS cluster)AMB/IQS-associated signalsModulation of PQS, Rhl outputs, virulence tuningActivated under phosphate limitation; CF relevanceLee and Zhang (2015b), Tuon et al. (2022) Table 1QS mediated virulence, adaptation, and social dynamics in P. aeruginosaQS systemKey componentsSignal molecule(s)Major regulated functionsSpecific functionReferencesLasLasI (synthase), LasR (regulator)3-oxo-C12-HSLElastase, exotoxin A, proteases, initiation of QS cascadeTop of hierarchy in PAO1; often mutated in CF isolatesSchuster and Greenberg (2006), Jimenez et al. (2012)RhlRhlI, RhlRC4-HSLRhamnolipids, hydrogen cyanide, biofilm maturationCan function independently of Las under CF-like conditionsSoto-Aceves et al. (2021), Asfahl et al. (2022PQSPqsABCDE, PqsH, PqsR (MvfR)PQS, HHQPyocyanin, iron chelation, biofilm structureNegatively regulated by Rhl; interacts with iron metabolismLin et al. (2018), Wilder et al. (2011)IQS/AmbAmbBCDE (NRPS cluster)AMB/IQS-associated signalsModulation of PQS, Rhl outputs, virulence tuningActivated under phosphate limitation; CF relevanceLee and Zhang (2015b), Tuon et al. (2022) QS mediated virulence, adaptation, and social dynamics in P. aeruginosa QS in P. aeruginosa is a complex system involved in the secretion of extracellular public goods including proteases (e.g., LasB), siderophores, and biosurfactants, which are metabolically costly but beneficial within bacterial communities. In chronic CF lung infections, loss-of-function mutations in the master QS regulator LasR frequently arise. These LasR-null variants behave as social cheaters, benefiting from public goods produced by QS-proficient neighbors while avoiding metabolic costs (Sandoz et al. 2007; Diggle et al. 2007). Recent studies show that cheating in CF lung infections has shifted from passive exploitation to active metabolite specialization and cross-feeding. LasR-null mutants alter central carbon metabolism, increasing activity of the CbrAB regulatory system, which promotes uptake and utilization of organic acids such as citrate and succinate released by QS-proficient cells (Popat et al. 2012; Mould et al. 2024). This metabolic shift enables LasR-deficient strains to persist and outcompete QS-intact populations under nutrient-limited and biofilm-associated CF airway conditions. Experimental and clinical studies further confirm the plasticity of QS hierarchies in CF isolates. In many LasR-null strains, the RhlR system becomes independent of LasR, enabling rhamnolipid production and other virulence traits without LasR signaling (Feltner et al. 2016; Kostylev et al. 2019). These strains blur the boundary between cooperators and cheaters, forming hybrid phenotypes that retain pathogenic potential while reducing metabolic burden. This enhances population resilience and supports long-term stability of mixed QS phenotypes in chronic CF infections (Table 3). Table 2Phenotypes of P. aeruginosa populations in chronic CF lung infection. Social and evolutionary phenotypes of P. aeruginosa populations identified in chronic CF lung infections. Long-term colonization promotes diversification into cooperative, cheating, QS-rewired, and hypermutator subpopulations. Interactions among these phenotypes, influenced by host-derived surfactants and spatial heterogeneity, enhance persistence and complicate therapeutic eradicationSocial phenotypeKey genetic featuresQS statusMetabolic characteristicsEcological role in CF lungClinical relevanceKey referencesQS-proficient (wild type–like)Intact lasR, rhlR, pqsRFully functional hierarchical QSHigh metabolic cost due to public-goods production (proteases, rhamnolipids)Produces shared virulence factors and maintains cooperative biofilm structureDrives tissue damage and inflammation; sensitive to QS disruptionSchuster and Greenberg (2006), Moradali et al. (2017)LasR-null “cheaters”Loss-of-function mutations in lasRLas system inactive; Rhl/Pqs variably activeReduced metabolic burden; enhanced uptake of organic acids (e.g., citrate)Exploit public goods produced by QS-proficient neighbors; persist in biofilmsCommon in CF isolates; associated with chronic infection and antibiotic toleranceSandoz et al. (2007), Popat et al. (2012), Mould et al. (2024)QS-rewired mutantslasR mutated but rhlR uncoupled from LasAlternative QS hierarchyRetain rhamnolipid and virulence production despite LasR lossMaintain cooperation while reducing QS regulatory costPreserve pathogenicity in chronic infectionFeltner et al. (2016), Kostylev et al. (2019)Hypermutator lineagesDefects in DNA mismatch repair (mutS, mutL)Variable; rapidly evolvingAccelerated diversification and adaptationGenerate population heterogeneity and resistance reservoirsLinked to multidrug resistance and treatment failureMena et al. (2008), Winstanley et al. (2016)Surfactant-adapted phenotypesAlterations in membrane and lipid metabolism genesQS prematurely activated by host lipidsUtilize host phospholipids; altered membrane dynamicsThrive in lipid-rich CF airway nichesEnhanced persistence and early virulence activationKuang et al. (2020), Jurado-Martín et al. (2021) Table 2Phenotypes of P. aeruginosa populations in chronic CF lung infection. Social and evolutionary phenotypes of P. aeruginosa populations identified in chronic CF lung infections. Long-term colonization promotes diversification into cooperative, cheating, QS-rewired, and hypermutator subpopulations. Interactions among these phenotypes, influenced by host-derived surfactants and spatial heterogeneity, enhance persistence and complicate therapeutic eradicationSocial phenotypeKey genetic featuresQS statusMetabolic characteristicsEcological role in CF lungClinical relevanceKey referencesQS-proficient (wild type–like)Intact lasR, rhlR, pqsRFully functional hierarchical QSHigh metabolic cost due to public-goods production (proteases, rhamnolipids)Produces shared virulence factors and maintains cooperative biofilm structureDrives tissue damage and inflammation; sensitive to QS disruptionSchuster and Greenberg (2006), Moradali et al. (2017)LasR-null “cheaters”Loss-of-function mutations in lasRLas system inactive; Rhl/Pqs variably activeReduced metabolic burden; enhanced uptake of organic acids (e.g., citrate)Exploit public goods produced by QS-proficient neighbors; persist in biofilmsCommon in CF isolates; associated with chronic infection and antibiotic toleranceSandoz et al. (2007), Popat et al. (2012), Mould et al. (2024)QS-rewired mutantslasR mutated but rhlR uncoupled from LasAlternative QS hierarchyRetain rhamnolipid and virulence production despite LasR lossMaintain cooperation while reducing QS regulatory costPreserve pathogenicity in chronic infectionFeltner et al. (2016), Kostylev et al. (2019)Hypermutator lineagesDefects in DNA mismatch repair (mutS, mutL)Variable; rapidly evolvingAccelerated diversification and adaptationGenerate population heterogeneity and resistance reservoirsLinked to multidrug resistance and treatment failureMena et al. (2008), Winstanley et al. (2016)Surfactant-adapted phenotypesAlterations in membrane and lipid metabolism genesQS prematurely activated by host lipidsUtilize host phospholipids; altered membrane dynamicsThrive in lipid-rich CF airway nichesEnhanced persistence and early virulence activationKuang et al. (2020), Jurado-Martín et al. (2021) Phenotypes of P. aeruginosa populations in chronic CF lung infection. Social and evolutionary phenotypes of P. aeruginosa populations identified in chronic CF lung infections. Long-term colonization promotes diversification into cooperative, cheating, QS-rewired, and hypermutator subpopulations. Interactions among these phenotypes, influenced by host-derived surfactants and spatial heterogeneity, enhance persistence and complicate therapeutic eradication Pulmonary surfactant alterations and their impact on P. aeruginosa in cystic fibrosis Pulmonary surfactant is a highly specialized lipid–protein complex that lines the alveoli and small airways, where it lowers surface tension to prevent alveolar collapse and supports efficient gas exchange. By mass, surfactant is made up of about 90% lipids and 10% proteins, with phospholipids forming the main lipid component (Fessler and Summer 2016). Among these, DPPC is the main surface-active molecule, along with phosphatidylglycerol (PG), phosphatidylserine, other minor glycerophospholipids, and neutral lipids such as cholesterol. Together, these components contribute to surfactant stability and host defense functions within BALF (Agassandian and Mallampalli 2013; Fessler and Summer 2016). The CF lung is characterized by profound alterations in surfactant composition and function. Chronic infection, persistent neutrophilic inflammation, impaired epithelial ion transport, and dehydrated mucus disrupt surfactant synthesis, recycling, and turnover (Tarran et al. 2005; Conese and Di Gioia 2021). BALF from CF patients shows reduced levels and impaired activity of surfactant proteins SP-A and SP-D, which are critical for opsonization, pathogen clearance, and modulation of inflammatory responses (von Bredow et al. 2001; Bruscia and Bonfield 2016). Multiple studies have reported reductions in total surfactant lipids, altered DPPC content, and accumulation of oxidized or dysfunctional phospholipid species in CF BALF (Schmidt et al. 2007; Agassandian and Mallampalli 2013) (Table 4). These compositional changes impair surfactant film stability, resulting in elevated surface tension and increased susceptibility to airway collapse and ventilation heterogeneity (Schmidt et al. 2007; Hall and Zuo 2024). These changes are further attributed to increased bacterial burden, heightened neutrophilic inflammation, and declining lung function (Noah et al. 2003; Griese et al. 2005) (Table 2). Table 3Alterations in surfactant phospholipids in CF and their effects on P. aeruginosaSurfactant componentNormal functionChange in CFEffect on P. aeruginosaReferencesDPPCReduces surface tensionAltered in CFMay influence QS-regulated virulence under experimental conditionsKuang et al. (2020)SP-AOpsonization, immune modulationDecreasedReduced bacterial clearanceHartl et al. (2005)SP-DPathogen aggregationReducedEnhanced bacterial survivalvon Bredow et al. (2001)Disaturated phospholipidsSurfactant stabilityDecreased ratioCorrelates with bacterial burdenNoah et al. 2003Host factor/lipidQS component affectedEvidence typeFunctional outcomeKey referenceBALF surfactant lipidsLas system (LasI/LasR)In vivo (murine pneumonia)Early elastase (LasB) expressionKuang et al. (2020)DPPCLas–Rhl hierarchyIn vitro / functionalPremature rhlA activationKuang et al. (2020)Host membrane lipidsPQS–OMV associationBiophysicalEnhanced signal stabilityMashburn-Warren et al. (2008)Degraded phospholipidsPQS-linked metabolismMetabolic / geneticAltered QS outputConstantino-Teles et al. (2022a, b) Table 3Alterations in surfactant phospholipids in CF and their effects on P. aeruginosaSurfactant componentNormal functionChange in CFEffect on P. aeruginosaReferencesDPPCReduces surface tensionAltered in CFMay influence QS-regulated virulence under experimental conditionsKuang et al. (2020)SP-AOpsonization, immune modulationDecreasedReduced bacterial clearanceHartl et al. (2005)SP-DPathogen aggregationReducedEnhanced bacterial survivalvon Bredow et al. (2001)Disaturated phospholipidsSurfactant stabilityDecreased ratioCorrelates with bacterial burdenNoah et al. 2003Host factor/lipidQS component affectedEvidence typeFunctional outcomeKey referenceBALF surfactant lipidsLas system (LasI/LasR)In vivo (murine pneumonia)Early elastase (LasB) expressionKuang et al. (2020)DPPCLas–Rhl hierarchyIn vitro / functionalPremature rhlA activationKuang et al. (2020)Host membrane lipidsPQS–OMV associationBiophysicalEnhanced signal stabilityMashburn-Warren et al. (2008)Degraded phospholipidsPQS-linked metabolismMetabolic / geneticAltered QS outputConstantino-Teles et al. (2022a, b) Alterations in surfactant phospholipids in CF and their effects on P. aeruginosa Table 4Alterations in surfactant phospholipids in CF and their effects on P. aeruginosaCF surfactant changeEffect on lungEffect on P. aeruginosaKey references↓ DPPC↑Surface tensionEarly QS activationKuang et al. (2020)Oxidized lipidsInflammationAltered metabolismFaure et al. (2018)↓ SP-A/SP-DPoor clearancePersistenceHartl et al. (2005) Table 4Alterations in surfactant phospholipids in CF and their effects on P. aeruginosaCF surfactant changeEffect on lungEffect on P. aeruginosaKey references↓ DPPC↑Surface tensionEarly QS activationKuang et al. (2020)Oxidized lipidsInflammationAltered metabolismFaure et al. (2018)↓ SP-A/SP-DPoor clearancePersistenceHartl et al. (2005) Alterations in surfactant phospholipids in CF and their effects on P. aeruginosa Apart from mechanical and immune functions, surfactant alterations can also shape bacterial behavior within the CF airway. Studies report that DPPC and related surfactant lipids can act as molecular switches, triggering QS-dependent virulence traits in P. aeruginosa, including elastases, rhamnolipids, and other tissue-damaging factors (Kuang et al. 2020). These findings demonstrate that pulmonary surfactant phospholipids can modulate quorum-sensing-dependent virulence responses in P. aeruginosa under controlled experimental conditions. However, the extent to which cystic fibrosis-associated alterations in surfactant composition contribute to quorum-sensing regulation within the complex in vivo lung environment remains unclear. While these observations support a potential role for host-derived surfactant lipids in shaping bacterial signaling, further studies are required to determine whether such effects occur under physiological conditions and significantly influence disease progression in cystic fibrosis. Therefore, current evidence supports an association between surfactant lipid composition and bacterial signaling responses, but a direct causal role in driving virulence activation in vivo has not yet been established. (Faure et al. 2018; Conese and Di Gioia 2021; Kuang et al. 2020). Role of surfactants in reshaping microbial cooperation of P. aeruginosa in cystic fibrosis Biosurfactants play a key role in microbial social behavior of P. aeruginosa in CF lung infection. P. aeruginosa produces glycolipid biosurfactants known as rhamnolipids, which have been detected in the sputum of patients with cystic fibrosis (CF) and whose production is regulated by QS Systems (Briard et al. 2017). These amphiphilic molecules lower surface tension and enable collective motility behaviors including swarming and surfing. This molecule also facilitates spatial organization, dispersal and nutrition access in the viscous CF mucus environment (Warrell et al. 2024). Rhamnolipids serve as structural regulators of biofilms, regulating the open water channels that allows nutrient diffusion, waste elimination, and population stratification within multicellular communities (Davey et al. 2003). By stabilizing the cooperative biofilm structures, surfactants indirectly manage QS public goods and protect from exploitation by non-producing cells. Rhamnolipids can inhibit the growth or spreading of competing species such as Staphylococcus aureus in the CF airways by direct disruption of cell membrane and causing spatial separation within mixed-species biofilms. (Briard et al. 2017; Bru et al. 2023). Additionally, the interaction between the bacterial surfactants and the host derived lung surfactant facilitates the microbial attachment and access to oxygen rich niches. Hence the surfactants act as an Ecological engineer by allowing both cooperative multicellular organization and competitive interactions within the CF airway microbiome (Constantino-Teles et al. 2022a, b; Flemming et al. 2016; Bjarnsholt et al. 2013). Within the cystic fibrosis lung, the biological functions of rhamnolipids extend beyond their general roles in motility and biofilm architecture. The CF airway is characterized by thick mucus, chronic inflammation, altered nutrient availability, and polymicrobial colonization, all of which create selective pressures that influence microbial behavior. Under these conditions, rhamnolipid production may facilitate spatial organization within biofilms, improve access to nutrients trapped within mucus, and modulate interactions with coexisting microorganisms such as Staphylococcus aureus and Aspergillus fumigatus. These activities may contribute to the long-term persistence and ecological adaptation of P. aeruginosa in the CF lung. Furthermore, by influencing microbial competition and community structure, biosurfactants may indirectly affect quorum-sensing dynamics and virulence expression within chronic CF airway infections (Bru et al. 2023; Briard et al. 2017; Constantino-Teles et al. 2022a, b; Winstanley et al. 2016). Modulation of QS circuits by lung surfactant Recent studies have shown that surfactant phospholipids found in BALF act as signals from the host environment that can trigger quorum-sensing (QS)–dependent virulence programs prematurely in P. aeruginosa. Using a murine model of acute pneumonia, researchers demonstrated that BALF exposure caused early production of the Las autoinducer N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C12-HSL), leading to precocious expression of QS-regulated virulence determinants such as elastase B (lasB) and the rhamnolipid biosynthesis gene rhlA, independent of canonical growth-phase regulation (Kuang et al. 2020). This work offers direct in vivo proof that lung surfactant components bypass the traditional cell-density thresholds that normally control QS activation. While researchers are still working to identify exactly which surfactant components drive this effect, phospholipids—especially DPPC appear to be key players (Fig. 1). Several studies have documented lipid-dependent regulation within bacterial signaling pathways. For example, PQS molecules are associated with bacterial membranes and outer membrane vesicles, influencing signal stability and distribution (Mashburn and Whiteley 2005). While this represents an intrinsic bacterial mechanism, it highlights how lipid environments can modulate quorum-sensing signal dynamics. However, direct interactions between host-derived lipids and these signaling pathways remain incompletely understood and require further investigation. Fig. 1Lung surfactant–mediated modulation of QS in P. aeruginosa in CF lung environment. Schematic representation of the role of altered lung surfactants in modulating QS mediated virulence of P. aeruginosa in CF lungs. This schematic highlights the potential of lung surfactant components and their synthetic analogues as therapeutic modulators targeting QS mediated virulence in P. aeruginosa infections in cystic fibrosis. The CF lung environment is enriched with host-derived surfactant phospholipids that interact with P. aeruginosa during infection. Natural surfactant components can promote premature activation of quorum-sensing (QS) circuits by influencing acyl-homoserine lactone (AHL) signaling and QS receptor activity (LasR, RhlR, and PqsR), leading to early expression of QS-regulated virulence factors such as elastase (LasB) and rhamnolipids. Synthetic surfactant analogues are proposed to interfere with this process by altering membrane-associated signal perception, disrupting local AHL accumulation, or competitively modulating QS receptor activation. Such host-inspired antivirulence strategies may attenuate pathogenicity and biofilm-associated persistence without directly affecting bacterial viability, offering a complementary approach to conventional antibiotic therapy in chronic CF lung infection. Lung surfactant–mediated modulation of QS in P. aeruginosa in CF lung environment. Schematic representation of the role of altered lung surfactants in modulating QS mediated virulence of P. aeruginosa in CF lungs. This schematic highlights the potential of lung surfactant components and their synthetic analogues as therapeutic modulators targeting QS mediated virulence in P. aeruginosa infections in cystic fibrosis. The CF lung environment is enriched with host-derived surfactant phospholipids that interact with P. aeruginosa during infection. Natural surfactant components can promote premature activation of quorum-sensing (QS) circuits by influencing acyl-homoserine lactone (AHL) signaling and QS receptor activity (LasR, RhlR, and PqsR), leading to early expression of QS-regulated virulence factors such as elastase (LasB) and rhamnolipids. Synthetic surfactant analogues are proposed to interfere with this process by altering membrane-associated signal perception, disrupting local AHL accumulation, or competitively modulating QS receptor activation. Such host-inspired antivirulence strategies may attenuate pathogenicity and biofilm-associated persistence without directly affecting bacterial viability, offering a complementary approach to conventional antibiotic therapy in chronic CF lung infection. Host–pathogen interactions and QS Modulation in a lipid-rich microenvironment The lipid-rich airway environment in CF lungs provides both nutrients and regulatory signals that are actively used by opportunistic pathogens such as P. aeruginosa. Research using in vitro models, animal studies, and clinical isolates shows that P. aeruginosa can detect and break down host-derived phosphatidylcholine, which triggers phospholipase activity and fatty-acid metabolic pathways that support bacterial growth and biofilm matrix formation (Son et al. 2007; Yin et al. 2022a, b). The released fatty acids can be used directly as carbon sources or built into bacterial membranes and biofilm components, helping the bacteria survive in nutrient-poor conditions. In addition to acting as nutrients, surfactant lipids also influence bacterial behavior. Certain phospholipids affect motility, QS signal production, phenazine synthesis, and biofilm structure, thereby controlling virulence expression depending on the environment (Curran et al. 2018; Kuang et al. 2020). Importantly, host-derived surfactant phospholipids such as DPPC can serve as molecular signals that activate quorum-sensing-controlled virulence pathways early in P. aeruginosa, directly connecting host lipid imbalance to bacterial pathogenic behavior (Kuang et al. 2020). In addition, P. aeruginosa can utilize phosphatidylcholine, a major component of lung surfactant, as a nutrient source. Enzymatic cleavage of phosphatidylcholine releases fatty acids, glycerol, and choline, which are further metabolized to support bacterial growth and persistence in the lung environment (Sun et al. 2014). At the same time, surfactant lipids and their associated proteins strongly regulate immune cell activity, particularly in neutrophils and macrophages. In CF, oxidation and imbalance of lipid species disrupt this regulation, reducing phagocytic clearance while maintaining inflammation that further alters the airway environment (Bruscia and Bonfield 2016; Fessler and Summer 2016). The combined effects of altered surfactant biophysics, bacterial lipid metabolism, and immune dysfunction create uneven microenvironments with limited diffusion, changing nutrient levels, and inconsistent immune pressure. These conditions promote bacterial phenotypic diversity, flexible QS responses, and strong biofilm stability, which together explain the chronic nature and treatment resistance of CF lung infections (Faure et al. 2018; Yin et al. 2022a, b). Pulmonary surfactant coats the airway surface and is rich in DPPC, which helps keep surface tension low and supports immune balance under normal healthy conditions (A). In CF, long-term inflammation, neutrophil-derived protease activity, and defective epithelial processing cause both quantitative and qualitative changes in surfactant composition, including lower DPPC levels and the build-up of oxidized and fragmented phospholipids (B). These changes weaken the physical function of surfactant and interfere with immunomodulatory signaling in the airway microenvironment. Altered surfactant lipids then serve as metabolic nutrients and regulatory signals for P. aeruginosa, encouraging lipid detection, activation of quorum-sensing–dependent virulence pathways, and long-term biofilm survival (C). Together, surfactant dysfunction and bacterial adaptation create a favorable niche that supports chronic infection and ongoing lung damage in CF. Recent transcriptomic studies indicate that host-derived surfactant lipids can influence QS–regulated gene expression in P. aeruginosa. Exposure to BALF has been shown to significantly increase the expression of QS-dependent virulence genes such as lasB and rhlA compared with standard laboratory conditions (Kuang et al. 2020). This coordinated activation suggests modulation of the QS regulatory network, including LasR-, RhlR-, and PQS-associated pathways, which are known to control overlapping virulence programs (Schuster and Greenberg 2006; Miranda et al. 2022). These findings support the concept that surfactant phospholipids act as host-derived signals that alter QS-mediated gene expression and virulence regulation in P. aeruginosa (Table 2). Discovery of surfactant-responsive receptors and signaling pathways Proposed mechanisms: membrane interaction, signal mimicry, and metabolic integration Researchers have put forward several mechanisms (which are not mutually exclusive) to explain how surfactant phospholipids affect QS circuitry in P. aeruginosa. A leading model centers on direct contact between phospholipids and bacterial membranes. Surfactant phospholipids may incorporate into the outer membrane or outer membrane vesicles (OMVs), where they change membrane fluidity, permeability, and how microdomains are organized, all of which influence how QS signals move around and reach their receptors (Mashburn-Warren et al. 2008). Because acyl-homoserine lactones and quinolone signals are hydrophobic, they tend to accumulate within lipid-rich microdomains, building up locally. This may reduce the threshold required for QS activation. Another possibility is that host lipids functionally mimic the bacteria’s own lipid signals. The fact that DPPC boosts QS-dependent virulence expression hints that surfactant phospholipids may share functional properties with bacterial lipid-associated signaling molecules to prematurely activate the Las and Rhl systems (Kuang et al. 2020). Essentially, host lipids could serve as stand-ins for autoinducers or could amplify how signals interact with their receptors. Finally, P. aeruginosa breaks down surfactant phospholipids using phospholipases, which produces fatty acid byproducts. These byproducts may get funneled into QS-related metabolic routes or work as extra signaling molecules themselves (Constantino-Teles et al. 2022a, b). This metabolic crossover ties together lipid breakdown, membrane restructuring, and QS control a complex example of cross-kingdom communication. Put together, these mechanisms paint a picture where host lipid environments are not just supporting bacterial growth—they are actually rewiring QS through physical changes to membranes, signal lookalikes, and metabolic connections. This is especially relevant in CF, where the surfactant’s makeup is entirely different. In that context, lipid-driven QS alterations likely elucidate the early onset of virulence, the persistence of biofilms, and chronic nature of infections. Therefore, surfactant phospholipids work as QS modulators from the host that can bypass canonical cell-density-dependent regulation, letting P. aeruginosa turn on virulence programs early in an infection—especially in CF lungs where surfactant lipid homeostasis is disrupted. Transposon mutagenesis and genome-wide fitness approaches Transposon mutagenesis has played a crucial role in finding genes that help with environmental sensing, virulence control, and adapting to the host in P. aeruginosa. Early work using large transposon libraries along with phenotypic screens allowed researchers to identify, without bias, genes linked to membrane integrity, regulatory signaling, and QS many critical for causing disease in living organisms (Liberati et al. 2006). These early studies were not specifically aimed for surfactant-responsive receptors, but they did find a lot of membrane-linked proteins, transporters, and regulators needed for bacteria to survive in a host-like environment. Later on, high-throughput methods like Tn-seq, INSeq, and TraDIS made it possible to measure gene fitness more precisely when bacteria were growing in BALF, mouse lungs, and similar lung infection setups (Skurnik et al. 2013; Turner et al. 2015). What these studies showed was that knocking out genes for outer membrane remodeling, lipid metabolism, two-component regulation systems, and signal transduction really affect the bacterial survival in the lungs. Interestingly, a lot of these genes seemed to be involved in sensing or reacting to hydrophobic signals from the host, not just responding to nutrient shortages. The recurrent identification of lipid-responsive pathways and membrane-associated regulators across independent genetic screens supports the concept that P. aeruginosa can sense lipid-heavy host environments. The absence of an identified DPPC receptor suggests that the molecular basis of bacterial surfactant sensing remains incompletely understood. Nevertheless, genome-wide functional studies provide a powerful roadmap for uncovering the bacterial determinants that mediate surfactant-driven virulence regulation (Son et al. 2007; Kuang et al. 2020). Evidence for uncharacterized receptors sensing DPPC and BALF components Even though there is functional proof that surfactants activate QS, the receptors for DPPC or complete BALF components are still unknown. That said, several experiments hint strongly at some kind of specialized detection system. When P. aeruginosa gets exposed to BALF or purified surfactant phospholipids, it starts making QS-regulated virulence factors prematurelyeven when bacterial numbers are still low. If you break down the phospholipids with enzymes, this early activation disappears (Kuang et al. 2020). These findings suggest the lipid molecules themselves are what matter, not some secondary inflammatory signals. Previous studies have shown that P. aeruginosa makes a wide variety of periplasmic and outer membrane proteins that can bind fatty acids and phospholipids, especially when it is infecting the lungs (Son et al. 2007). Most research on these proteins has focused on lipid uptake and membrane remodeling, but specific receptors have not yet been identified whether they also play a role in detecting signals. On top of that, membrane-bound transcriptional regulators and sensor kinases can react to changes in membrane makeup and hydrophobic molecules from the host. This offers a reasonable explanation for how bacteria may sense lipids without needing the usual ligand–receptor pairing (Goodman et al. 2004). Surfactant phospholipids can wedge themselves into bacterial membranes, changing how fluid the membrane is, its curvature, and how its microdomains are arranged. Sensors embedded in the membrane may pick up on these physical changes indirectly, then kick off regulatory responses downstream (Fessler and Summer 2016). This fits with how bacteria generally detect host environments—sometimes physical shifts in the membrane stand in for direct binding between a ligand and its receptor (Goodman et al. 2004). So even though we have not nailed down specific receptors for DPPC or BALF yet, the genetic, biochemical, and physiological data all point to some kind of specialized sensing setup tuned to surfactant-based cues. Signal transduction pathways linking surfactant sensing to QS In P. aeruginosa, there are several signal transduction routes connecting surfactant lipid detection to quorum-sensing activation. Two-component regulatory systems (TCSs) are key for converting signals from outside the cell or from the membrane into changes in gene expression. Many P. aeruginosa sensor kinases respond to hydrophobic compounds, membrane stress, or signals tied to the host, making them likely candidates for relaying surfactant-triggered signaling. (Goodman et al. 2004). When host phospholipids get incorporated and change the membrane’s lipid makeup, this may modulate sensor kinase activity, which then affects QS regulator expression and activity further down the line (Fessler and Summer 2016). At the same time, surfactant lipids may boost QS signaling indirectly by keeping acyl-homoserine lactones stable in lipid-rich pockets. This raises their local concentration and how far they can spread (Pearson et al. 1997; Mashburn-Warren et al. 2008). That matches up with experiments showing BALF speeds up Las-dependent autoinducer buildup and virulence gene activity (Kuang et al. 2020). Additionally, incorporation and metabolism of host-derived surfactant phospholipids may alter bacterial membrane composition and cellular physiology, thereby influencing regulatory pathways associated with virulence expression (Son et al. 2007; Kuang et al. 2020). Such effects are likely to occur indirectly through changes in membrane properties, metabolic adaptation, and signal transduction processes rather than through direct receptor-mediated interactions (Goodman et al. 2004; Fessler and Summer 2016). Collectively, these observations suggest that host surfactant lipids may modulate the regulatory environment in which quorum-sensing networks operate. QS inhibition using synthetic surfactant analogues: antivirulence therapy as an alternative strategy Anti-virulence therapy represents an alternative therapeutic strategy that targets pathogenic behaviors of P. aeruginosa in CF. Because P. aeruginosa rapidly develops resistance to conventional antibiotics, targeting regulatory pathways controlling virulence has gained significant attention. Anti-virulence strategies aim to disrupt QS, thereby attenuating virulence factor production, impairing biofilm maturation, and reducing host tissue damage without directly inhibiting bacterial growth. This approach minimizes selective pressure for resistance antibiotics (Scoffone et al. 2019; Duplantier et al. 2021). The QS system regulates expression of multiple virulence factors, including elastases, rhamnolipids, and phenazines, which contribute to biofilm formation and persistence in CF lungs. Quorum-quenching approaches interfere with QS signaling through several mechanisms, including competitive inhibition of signal receptors, degradation of autoinducers, and inhibition of signal synthesis enzymes. For example, synthetic acyl-homoserine lactone (AHL) analogues competitively bind to LasR and RhlR receptors, preventing transcription of virulence genes, while enzymatic degradation of AHL molecules by lactonases or acylases disrupts signal accumulation. These approaches have demonstrated reduced virulence and impaired biofilm formation in laboratory strains and CF-derived isolates (Collalto et al. 2022; Duplantier et al. 2021). Non-antibiotic QS inhibitors target key regulatory circuits, including the Las, Rhl, and Pqs systems, thereby disrupting coordinated pathogenic behaviors. These inhibitors reduce biofilm formation, attenuate virulence factor production, and enhance susceptibility to host immune responses and antibiotics without imposing bactericidal pressure (Duplantier et al. 2021). Synthetic surfactant analogues may act as QS modulators by mimicking host lipid signals in the lung environment. These molecules can interfere with QS-dependent signaling pathways and reduce virulence in a mechanism-dependent manner. Although still at a conceptual stage, emerging evidence suggests that surfactant-derived lipids influence bacterial communication and represent promising lipid-inspired antivirulence therapeutics (Kuang et al. 2020). Combining QS inhibitors with conventional antibiotics or immunomodulatory therapies may therefore provide a robust strategy for treating chronic CF lung infections (Kalaiarasan et al. 2017). Lipid-based and quorum sensing-targeted therapeutic strategies Persistent P. aeruginosa infection in the lung microenvironment is the hallmark of CF, which is characterized by increased host lipids and altered pulmonary surfactants, thereby resulting in airway obstruction, increased inflammation, and enhanced adherence of the pathogen. In preclinical studies, components of lung surfactants were shown to influence bacterial behaviors, antibiotic resistance and tolerance, biofilm formation and virulence (Scoffone et al. 2019). DPPC is a major constituent of lung surfactant, and its role in P. aeruginosa mediated CF pathophysiology is known. DPPC is utilized as a carbon source in the nutrient depleted lung environment and also influences positive regulation of virulence and biofilm formation. Thus, surfactant–pathogen interactions offer potential for the development of translational therapeutics such as synthetic DPPC analogues which retain biophysical compatibility and may aid in mitigating microbial load, serving as anti-virulence or anti-biofilm therapies (Kuang et al. 2020). Several lipid-based therapeutics are currently available for pulmonary disorders, enabling transition of DPPC-based analogues to the clinical setting as an adjunctive therapeutic option targeting P. aeruginosa persistence (Winstanley et al. 2016). Furthermore, when combined with antibiotic therapy, this approach may affect pathogen fitness and hamper evolution of antibiotic resistance (Duplantier et al. 2021). P. aeruginosa strains with defects in QS affect bacterial colonization of lung tissues in vivo, suggesting compromised bacterial persistence, decreased bacterial load, and reduced biofilm formation. In animal models of CF, anti-virulence and anti-QS approaches show decreased inflammatory infiltration, reduced epithelial damage, and maintenance of alveolar structure (Scoffone et al. 2019; Kuang et al. 2020). Additionally, this promotes improved clearance of the pathogen by host immunity, highlighting the therapeutic significance of inhibition of microbial quorum (Duplantier et al. 2021). Longitudinal studies of CF in animal infection models also select for isolates impaired in QS. Collectively, these findings emphasize the importance of targeting QS and its potential as a promising therapeutic option in treating P. aeruginosa infections in CF (Winstanley et al. 2016). Future directions and knowledge gaps in lipid-mediated quorum sensing in cystic fibrosis The CF airway contains elevated levels of surfactant phospholipids, fatty acids, and inflammatory lipid mediators that may influence P. aeruginosa physiology, QS, and biofilm formation. Although evidence suggests that P. aeruginosa responds to host-derived lipids, the extent of lipid-mediated QS regulation and its role in CF disease progression remains poorly understood (Kuang et al. 2020; Scoffone et al. 2019). Additionally, mutations in QS regulatory genes such as lasR in CF-adapted strains highlight the need to distinguish QS dynamics between acute and chronic infections (Winstanley et al. 2016). Current CF models also inadequately represent the lung lipid environment, emphasizing the need for improved in vivo models and longitudinal sampling approaches (Mena et al. 2008; Nguyen and Singh 2006). Although QS signaling pathways involving LasR, RhlR, and PqsR are well characterized in vitro, their activity in the complex CF lung environment remains incompletely understood. Host factors such as immune responses, nutrient availability, oxygen gradients, and polymicrobial interactions may alter QS signaling and virulence outcomes in vivo (Nguyen and Singh 2006; Winstanley et al. 2016). Furthermore, QS-mediated virulence observed in vitro does not consistently correlate with disease severity in vivo, highlighting the need for physiologically relevant models and longitudinal clinical studies to validate QS-targeted therapeutic strategies (Kuang et al. 2020). Conclusion Pseudomonas aeruginosa remains one of significant pathogens contributing to chronic lung disease causing progressive respiratory decline in patients with cystic fibrosis. While QS has long been recognized as a central regulator of virulence, biofilm formation, and persistence, emerging evidence indicates that host-derived pulmonary surfactant lipids are not merely passive components of the airway environment but may also actively influence bacterial signalling networks. Surfactant phospholipids such as dipalmitoylphosphatidylcholine (DPPC) appear to be capable of modulating QS, promoting virulence gene expression, biofilm development, and long-term adaptation within the cystic fibrosis lung. The precise molecular mechanisms and receptors involved in surfactant sensing remain incompletely understood, however earlier literature supports the concept that lipid-rich airway microenvironments may reshape bacterial behaviour and contribute to infection persistence. Future investigations should focus on identifying the molecular pathways responsible for surfactant-mediated signaling, validating these mechanisms in clinically relevant models, and evaluating lipid-based quorum-sensing inhibitors as potential adjunctive therapies.